Secukinumab
- Product NameSecukinumab
- CAS1229022-83-6
- CBNumberCB12744217
- MW0
- EINECS-0
- MDL NumberMFCD01092388
- MOL FileMol file
Secukinumab Chemical Properties,Usage,Production
Uses
Secukinumab (AIN457) is a high affinity, human monoclonal antibody targeted against interleukin (IL)-17A. Secukinumab is the first-in-class anti-IL-17 agent used for the research of plaque psoriasis, ankylosing spondylitis and psoriatic arthritis[1][2].Clinical Use
Human IgG1/κ monoclonal antibody:Treatment of moderate to severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis
Drug interactions
Potentially hazardous interactions with other drugsVaccines: risk of generalised infections with live vaccines - avoid.
IC 50
IL-17AMetabolism
The majority of IgG elimination occurs via intracellular catabolism, following fluid-phase or receptor mediated endocytosis.References
[1] Shirley M, et al. Secukinumab: A Review in Psoriatic Arthritis. Drugs. 2016;76(11):1135-1145. DOI:10.1007/s40265-016-0602-3[2] Reich K, et al. Secukinumab dosing optimization in patients with moderate-to-severe plaque psoriasis: results from the randomized, open-label OPTIMISE study. Br J Dermatol. 2020;182(2):304-315. DOI:10.1007/s40265-016-0602-3
[3] Elain G, et al. The selective anti-IL17A monoclonal antibody secukinumab (AIN457) attenuates IL17A-induced levels of IL6 in human astrocytes. Glia. 2014;62(5):725-735. DOI:10.1002/glia.22637
Secukinumab Suppliers
Global(44)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| +1-781-999-5354; +1-00000000000 | marketing@targetmol.com | 32430 | 58 | ||
| +8618062405514 | ada@ipurechemical.com | 10223 | 58 | ||
| +86-29-81148696 +86-15129568250 | 1022@dideu.com | 29083 | 58 | ||
| 16314854226; +8616314854226 | inquiry@bocsci.com | 19852 | 58 | ||
| +86-18327326525 | masar@topule.com | 8432 | 58 | ||
| tp@aladdinsci.com | 54731 | 58 | |||
| sales@kdg-tech.com | 931 | 58 | |||
| 18916372613 | yanzihan@shyuanye.com | 87240 | 60 | ||
| 021-31433387 15618786686 | sales@rechemscience.com | 2968 | 58 | ||
| 27-027-83314682 13554138826 | whsrtech@vip.163.com | 266 | 62 |